Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14
Frequently Asked Questions
What is Market Cap of Aravive Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aravive Inc market cap is $67.55M.
What is the 52-week high for Aravive Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aravive Inc 52 week high is $13.50 as of September 08, 2025.
What is the 52-week low for Aravive Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aravive Inc 52 week low is $3.07 as of September 08, 2025.
What is Aravive Inc stock price today?
Aravive Inc stock price today is $5.94.
What was Aravive Inc stock price yesterday?
Aravive Inc stock price yesterday was $5.99.
What is the PE ratio of Aravive Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aravive Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Aravive Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aravive Inc P/B ratio is 1.2290.
What is Aravive Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aravive Inc's EBITDA is -1.24.
What is the 50-day moving average of Aravive Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aravive Inc 50-day moving average is $6.10.